Lupin gets USFDA nod to market generic Doxercalciferol injection

Lupin gets USFDA nod to market generic Doxercalciferol injection The company has received approval from the United States Food and Drug Administration (USFDA) to market its Doxercalciferol injection, 4 mcg/2 mL (2 mcg/mL) multi-dose vials, Lupin said in a statement.

from Moneycontrol Business News
Read The Rest:moneycontrol...